These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 880876)

  • 1. Naltrexone treatment of opiate-dependent persons.
    Hollister LE; Schwin RL; Kasper P
    Drug Alcohol Depend; 1977 May; 2(3):203-9. PubMed ID: 880876
    [No Abstract]   [Full Text] [Related]  

  • 2. Naltrexone in the treatment of opiate dependence.
    Resnick RB; Washton AM; Thomas MA; Kestenbaum RS
    NIDA Res Monogr; 1978; (19):321-32. PubMed ID: 218108
    [No Abstract]   [Full Text] [Related]  

  • 3. Naloxone-precipitated withdrawal: a method for rapid induction onto naltrexone.
    Resnick RB; Kestenbaum RS; Washton A; Poole D
    Clin Pharmacol Ther; 1977 Apr; 21(4):409-13. PubMed ID: 849672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update of naltrexone treatment.
    O'Brien CP; Greenstein R; Woody GE
    NIDA Res Monogr; 1978; (19):315-20. PubMed ID: 218107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experiences with naltrexone in 370 detoxified addicts.
    Thomas M; Kauders F; Harris M; Cooperstein J; Hough G; Resnick R
    NIDA Res Monogr; 1976 Sep; (9):88-92. PubMed ID: 794726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of naltrexone use--its efficacy, safety and potential.
    Landsberg R; Taintor Z; Plumb M; Amico L; Wicks N
    NIDA Res Monogr; 1976 Sep; (9):106-13. PubMed ID: 1004529
    [No Abstract]   [Full Text] [Related]  

  • 7. Comments and findings from a naltrexone double blind study.
    Keegan J; Lavenduski C; Schooff K
    NIDA Res Monogr; 1976 Sep; (9):74-6. PubMed ID: 794724
    [No Abstract]   [Full Text] [Related]  

  • 8. [Role of LAAM, methadone and naltrexone in the care of opiate dependence. Experience in Portugal].
    Patricio LD; Miguel N
    Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():28-30. PubMed ID: 7880010
    [No Abstract]   [Full Text] [Related]  

  • 9. Multiple family therapy and naltrexone in the treatment of opiate dependence.
    Anton RF; Hogan I; Jalali B; Riordan CE; Kleber HD
    Drug Alcohol Depend; 1981 Sep; 8(2):157-68. PubMed ID: 7318681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naltrexone precipitated opiate withdrawal in methadone addicted human subjects: evidence for noradrenergic hyperactivity.
    Charney DS; Redmond DE; Galloway MP; Kleber HD; Heninger GR; Murberg M; Roth RH
    Life Sci; 1984 Sep; 35(12):1263-72. PubMed ID: 6482651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of sustained action preparations of narcotic antagonists.
    Willette RE
    NIDA Res Monogr; 1978; (19):333-9. PubMed ID: 218109
    [No Abstract]   [Full Text] [Related]  

  • 12. Abstinence treatments for opiate addicts: therapeutic community or naltrexone?
    Arndt I; McLellan AT; O'Brien CP
    NIDA Res Monogr; 1984 Mar; 49():275-81. PubMed ID: 6434972
    [No Abstract]   [Full Text] [Related]  

  • 13. Patient deaths in a narcotic antagonist (naltrexone) and l-alpha-acetylmethadol program.
    Schecter A; Kauders F
    Am J Drug Alcohol Abuse; 1975; 2(3-4):443-9. PubMed ID: 1227302
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of narcotic antagonists in the rehabilitation of opiate addicts: a review of naltrexone.
    Schecter A
    Am J Drug Alcohol Abuse; 1980; 7(1):1-18. PubMed ID: 6254356
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical evaluation of naltrexone treatment of opiate-dependent individuals. Report of the National Research Council Committee on Clinical Evaluation of Narcotic Antagonists.
    Arch Gen Psychiatry; 1978 Mar; 35(3):335-40. PubMed ID: 365122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonidine hydrochloride detoxification from methadone treatment--the value of naltrexone aftercare.
    Rawson RA; Washton AM; Resnick RB; Tennant FS
    Adv Alcohol Subst Abuse; 1984; 3(3):41-9. PubMed ID: 6093484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome with naltrexone.
    Resnick RB; Washton AM
    Ann N Y Acad Sci; 1978; 311():241-7. PubMed ID: 283722
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of narcotic antagonists (naltrexone) in an addiction treatment program.
    Lewis D; Hersch R; Black R; Mayer J
    NIDA Res Monogr; 1976 Sep; (9):99-105. PubMed ID: 794728
    [No Abstract]   [Full Text] [Related]  

  • 19. Clonidine hydrochloride detoxification from methadone treatments: the value of naltrexone aftercare.
    Rawson RA; Washton AM; Resnick RB; Tennant FS
    NIDA Res Monogr; 1981 Feb; 34():101-8. PubMed ID: 6783916
    [No Abstract]   [Full Text] [Related]  

  • 20. Varying clinical contexts for administering naltrexone.
    Hurzeler M; Gerwirtz D; Kleber H
    NIDA Res Monogr; 1976 Sep; (9):48-66. PubMed ID: 794721
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.